ARCHIVES

FDA Expands Nexavar Indication To Include Thyroid Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Levine, Mendelsohn Win Landon Awards; Ullrich Wins Pezcoller.

February 29, 2008

In Brief: NCI Grants Up Fourfold Since 1970; Rappaport, Jensen Speakers At Annual AACR,ASCO Meeting

April 25, 1975

NCI Amends FCRF RFP, Extends Deadline To Nov. 10

August 22, 1986

‘Helping Smokers Quit’ Program Launched By NCI, Pharmacist Group

June 27, 1986

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997